SKYE vs. ASST
SKYE (Skye Bioscience, Inc) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. SKYE operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, SKYE returned -41.13%/yr vs -49.05%/yr for ASST. At a 0.11 correlation, their price movements are largely independent.
Performance
SKYE vs. ASST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SKYE achieves a 2.71% return, which is significantly lower than ASST's 3.05% return.
SKYE
- 1D
- 5.02%
- 1M
- -10.75%
- YTD
- 2.71%
- 6M
- -36.36%
- 1Y
- -68.31%
- 3Y*
- -41.13%
- 5Y*
- -54.71%
- 10Y*
- -40.24%
ASST
- 1D
- 9.27%
- 1M
- -4.46%
- YTD
- 3.05%
- 6M
- -22.78%
- 1Y
- -86.80%
- 3Y*
- -49.05%
- 5Y*
- —
- 10Y*
- —
SKYE vs. ASST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
SKYE Skye Bioscience, Inc | 2.71% | -73.51% | 4.04% | -76.09% |
ASST Asset Entities Inc. Class B Common Stock | 3.05% | 50.46% | -84.65% | -82.00% |
Correlation
The correlation between SKYE and ASST is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Feb 6, 2023 | 0.11 |
The correlation between SKYE and ASST shifts across timeframes, from 0.11 (all time) to 0.25 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
SKYE:
$30.55M
ASST:
$937.39M
SKYE:
-$1.45
ASST:
-$25.54
SKYE:
$0.00
ASST:
$5.73M
SKYE:
-$180.01K
ASST:
-$7.43M
SKYE:
$10.92M
ASST:
-$304.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SKYE vs. ASST — Risk / Return Rank
SKYE
ASST
SKYE vs. ASST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SKYE | ASST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.07 | ||
| Sortino ratioReturn per unit of downside risk | +0.31 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.92 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | -0.91 | +0.13 |
| Martin ratioReturn relative to average drawdown | -1.04 | -1.12 | +0.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SKYE | ASST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.59 | -0.53 | -0.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.36 | -0.19 | -0.17 |
Drawdowns
SKYE vs. ASST - Drawdown Comparison
The maximum SKYE drawdown since its inception was -99.96%, roughly equal to the maximum ASST drawdown of -97.98%. Use the drawdown chart below to compare losses from any high point for SKYE and ASST.
Loading charts...
Drawdown Indicators
| SKYE | ASST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -97.98% | -1.98% |
Max Drawdown (1Y)Largest decline over 1 year | -87.85% | -95.98% | +8.13% |
Max Drawdown (3Y)Largest decline over 3 years | -96.79% | -97.25% | +0.46% |
Max Drawdown (5Y)Largest decline over 5 years | -98.66% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -99.83% | — | — |
Current DrawdownCurrent decline from peak | -99.94% | -95.72% | -4.22% |
Average DrawdownAverage peak-to-trough decline | -94.95% | -84.13% | -10.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 65.76% | 77.69% | -11.93% |
Volatility
SKYE vs. ASST - Volatility Comparison
Skye Bioscience, Inc (SKYE) has a higher volatility of 28.64% compared to Asset Entities Inc. Class B Common Stock (ASST) at 26.35%. This indicates that SKYE's price experiences larger fluctuations and is considered to be riskier than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SKYE | ASST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.64% | 26.35% | +2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 63.38% | 82.30% | -18.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 115.33% | 164.70% | -49.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 130.81% | 322.72% | -191.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 137.31% | 322.72% | -185.41% |
Dividends
SKYE vs. ASST - Dividend Comparison
Neither SKYE nor ASST has paid dividends to shareholders.
Financials
SKYE vs. ASST - Financials Comparison
This section allows you to compare key financial metrics between Skye Bioscience, Inc and Asset Entities Inc. Class B Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SKYE and ASST have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SKYE has higher volatility (28.64%) compared to ASST (26.35%). In terms of maximum drawdown, SKYE dropped -99.96% vs ASST's -97.98%.
ASST currently has the higher Sharpe Ratio (-0.53 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SKYE and ASST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer